Guest
Kevin O'Leary
#563: Kevin O’Leary on Investing in Bitcoin and Crypto
- Kevin's evolving stance on Bitcoin and crypto, from skepticism ("I forbid you") to institutional allocation of 3–5% in operating companies with plans to increase to 10%. - DeFi yield farming as core strategy: earning 4.5–8% on crypto holdings through smart contracts and decentralized lending, with plans to simplify via a new company called WonderFi (formerly DeFi Ventures). - Media and social platforms as value creation: using Shark Tank, CNBC, and direct audience reach to amplify company stories and build shareholder bases, beyond traditional venture capital. - Wine business scaling: achieving $5.1 million in QVC sales in 21 hours; partnership with Costco buyer led to profitability by targeting the $11–14 price point (97% of US wine market). - Bitcoin vs. gold rebalancing: gold holds 5% (yielding nothing and costing storage fees), while crypto now generates yield; likely to shift allocations as DeFi matures and proves safer. - ESG and regulatory headwinds: initial pushback from institutional clients over coal-mined Bitcoin, but softening as regulators in Switzerland, Germany, Canada, and UK approve Bitcoin ETFs.
#441: Kevin O’Leary on Alternative Assets
- The PPP loan program distributed capital inefficiently, with roughly one-third wasted on businesses unlikely to survive regardless of stimulus, while profitable companies pivoted successfully to direct-to-consumer models. - The pandemic accelerated online retail adoption by 36 months, forcing businesses to digitize and shift away from traditional retail; this trend is permanent and not reversing post-COVID. - Employee financial illiteracy revealed during lockdowns: 95% of workers in O'Leary's companies had less than two weeks of salary saved, prompting him to launch Beanstocks, an app that simplifies investing in diversified ETF portfolios. - Alternative assets including wine, watches, and psychedelics-as-medicine offer genuine investment potential; watches have appreciated 113% year-over-year, while psychedelics companies like MindMed avoid cannabis's regulatory pitfalls by pursuing only FDA-approved medical use cases. - Bitcoin remains volatile and problematic as a currency without regulatory clarity; institutional adoption is minimal, and O'Leary prefers a multi-cryptocurrency ETF approach rather than concentrated Bitcoin exposure. - O'Leary's portfolio construction emphasizes capital preservation: never more than 5% in any single asset, no more than 20% in any sector, 30% in private companies, 8% in real estate (down from 31%), and currently 34% in cash awaiting deployment.